About Cabaletta Bio (CABA)
Cabaletta Bio Inc. is a clinical-stage biotechnology company. The Company is focused on discovery and development of engineered T-cell therapies for B cell-mediated autoimmune diseases. The T cells are designed to selectively bind and eliminate B cel... Read more
- USD1.30
- USD1.31
- USD1.23
- USD13.50
- -23.50%
- --
- 209.00
- 980.65k
- 64M
- 0.99
- -89.60%
Stock News
34 minutes ago
Massive power outage strikes Spain and Portugal
MarketWatch
1 hour ago
Agriculture isn't nearing trade war tariffs crisis, 'it is full blown crisis already' farmers say
CNBC
4 hours ago
Risk-Off Following Familiar Pattern
SeekingAlpha
4 hours ago
Baron Emerging Markets Fund Q1 2025 Shareholder Letter
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
